ADHD Drug Use in U.S. Rose Among Ages 20-44
Posted on: Tuesday, 21 March 2006, 01:05 CST
WASHINGTON -- Use of attention deficit drugs rose nearly 19 percent among ages 20 to 44 in 2005 while falling 5 percent in children under 10, according to statistics released on Tuesday amid a U.S. review of the drugs' safety.
An estimated 1.7 million U.S. adults aged 20 to 64 and nearly 3.3 million children 19 and younger took a prescription drug to treat attention deficit hyperactivity disorder (ADHD) in 2005, according to a report from pharmacy benefits manager Medco Health Solutions Inc..
ADHD drugs include Novartis AG's Ritalin and Focalin, Shire Plc's Adderall and Johnson & Johnson's Concerta.
The biggest jump in use -- a 19 percent rise from 2004 -- was among adults ages 20 to 44, the study said. The number of those aged 10 to 19 who took the drugs rose by 2 percent.
Use fell 5 percent for children under 10. The findings were based on prescription data from 2.5 million U.S. patients.
Critics say ADHD drugs are overprescribed, especially among children. The safety of the medicines has faced growing scrutiny in recent months.
In February, a Food and Drug Administration advisory panel called for a strong "black-box" warning on ADHD medicines, saying they might increase the chances of cardiovascular problems in some patients. The FDA says it does not yet know if reports of sudden deaths, heart attacks and strokes are related to the drugs.
On Wednesday, a different FDA advisory panel is set to review data on a possible link between ADHD therapies and heart problems, as well as psychiatric problems such as hallucinations in children.
The FDA will consider the input from the panels before deciding whether to update warnings on the drug labels.
Source: REUTERS
Related Articles
- European Prices of 170 Best-Selling Drugs Averaged 40 Percent Less Than U.S. Prices in 2008
- New Approaches to Drug Development Will Drive Drug Company Success, According to Tufts Center for the Study of Drug Development
- Not All Drug Deaths Involve Illegal Drugs
- Prescription Drug Sales Rise 8.3 Percent
- Teens Turn Away From Street Drugs, Move to Prescription Drugs, New Report Reveals
- GSK's Offer Still Stands: Drug Maker Maintains Its Drug Giveaways for Low-Income Patients
- ADHD drug use in US rose among ages 20-44: study
- Barbeau Pharma Announces That Its Studies Of The Cardiotoxicity Of Drug Metabolites Are Consistent With Newly Issued FDA Recommendations For Assessing Pharmaceutical Cardiac Risk
- Drugs-Mexico: Small-Scale Drug Sales Up More Than 700 Percent
- Recent Drug Warnings May Spur Major Overhaul of FDA Safety Procedures
 |
 |
User Comments (0)
RSS Feeds